INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 9 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $16,662,000 | +13.7% | 14,750,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $14,649,000 | -1.0% | 14,750,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $14,791,000 | -0.8% | 14,750,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $14,917,000 | +5.9% | 14,750,000 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $14,086,000 | +13.0% | 14,750,000 | +31.1% | 0.01% | +33.3% |
| Q3 2018 | $12,462,000 | +57.2% | 11,250,000 | +45.2% | 0.01% | +50.0% |
| Q2 2018 | $7,927,000 | +6.3% | 7,750,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,455,000 | +30.8% | 7,750,000 | +3.3% | 0.00% | +33.3% |
| Q4 2017 | $5,700,000 | +29.7% | 7,500,000 | +25.0% | 0.00% | 0.0% |
| Q3 2017 | $4,395,000 | -14.5% | 6,000,000 | -29.4% | 0.00% | -25.0% |
| Q2 2017 | $5,143,000 | -20.6% | 8,500,000 | -19.0% | 0.00% | -33.3% |
| Q1 2017 | $6,476,000 | -57.9% | 10,500,000 | -30.0% | 0.01% | -62.5% |
| Q4 2016 | $15,394,000 | -24.4% | 15,000,000 | 0.0% | 0.02% | -20.0% |
| Q3 2016 | $20,364,000 | – | 15,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|